SEC Form 4 · accession 0001203311-18-000053
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger D Dansey
Officer — Chief Medical Officer
Period of report
Jun 15, 2018
Accepted (ET)
Jun 19, 2018 · 7:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 15, 2018 | A | 50,000 | $0.00 | A | 50,000 | D | |
| Common StockF1,F3 | Jun 15, 2018 | A | 20,000 | $0.00 | A | 70,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F4 | $65.11 | Jun 15, 2018 | A | 6,140 | A | — | Jun 15, 2028 | Common Stock | 6,140 | 6,140 | D |
| Non-Qualified Stock Option (right to buy)F4 | $65.11 | Jun 15, 2018 | A | 43,860 | A | — | Jun 15, 2028 | Common Stock | 43,860 | 43,860 | D |
Explanation of responses
- F1These shares represent restricted stock units and will be settled in common stock upon vesting.
- F2These restricted stock units shall vest in full three (3) years from grant date.
- F3These restricted stock units shall vest in two equal installments on the first and second anniversaries of the grant date.
- F4Shares shall vest at a rate of 25% one year from the grant date and monthly thereafter until all shares are fully vested four years from grant date.